Literature DB >> 7568627

Effects of neurotensin on EEG and event-related potentials in the rat.

P Robledo1, W M Kaneko, C L Ehlers.   

Abstract

Neurotensin has neuromodulatory actions on multiple brain functions including motor, sensory and limbic processes. However, little is known about how neurotensin affects general arousal and/or attention states. The present study evaluated the effects of neurotensin on spontaneous brain activity as well as auditory evoked responses using electrophysiological measures. Electroencephalographic and event-related potential recordings were obtained in awake animals following intracerebroventricular administration of neurotensin (1.0, 10.0 and 30.0 micrograms). Twenty rats were implanted with recording electrodes in the frontal cortex, dorsal hippocampus, amygdala and nucleus accumbens. Neurotensin was found to produce a dose-related effect on behavior and electrophysiological measures. Lower doses (10 micrograms) produced no obvious behavioral changes, but significantly reduced EEG power in the lower frequency ranges (2-6 Hz) in the frontal cortex, the anterior amygdaloid complex and the nucleus accumbens. At higher doses (30 micrograms), rats appeared behaviorally inactivated, and EEG power was reduced in all structures in both the lower frequency ranges (2-6 Hz) and the higher frequency ranges (8-32 Hz). Auditory processing, as assessed by event-related potentials, was affected most significantly in amygdala and dorsal hippocampus. In the amygdala, the amplitude of the P3 component of the auditory event-related potential was increased significantly by doses of 10.0 and 30.0 micrograms. In the dorsal hippocampus, the amplitude and the area of the N1 component was increased dose dependently and significance was reached at the 30 micrograms dose. These electrophysiological findings indicate that neurotensin does not reduce the arousal level of the animals and in fact may enhance neurosensory processing in limbic areas through increased arousal and/or enhanced stimulus evaluation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568627     DOI: 10.1007/BF02245941

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system.

Authors:  R P Dilts; P W Kalivas
Journal:  Brain Res       Date:  1989-05-29       Impact factor: 3.252

2.  Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain.

Authors:  M N Castel; P Morino; P Frey; L Terenius; T Hökfelt
Journal:  Neuroscience       Date:  1993-08       Impact factor: 3.590

Review 3.  General pharmacology of clozapine.

Authors:  D M Coward
Journal:  Br J Psychiatry Suppl       Date:  1992-05
  3 in total
  2 in total

1.  Altered sleep and affect in the neurotensin receptor 1 knockout mouse.

Authors:  Karrie Fitzpatrick; Christopher J Winrow; Anthony L Gotter; Joshua Millstein; Janna Arbuzova; Joseph Brunner; Andrew Kasarskis; Martha H Vitaterna; John J Renger; Fred W Turek
Journal:  Sleep       Date:  2012-07-01       Impact factor: 5.849

2.  Electrophysiological and hemodynamic mismatch responses in rats listening to human speech syllables.

Authors:  Mahdi Mahmoudzadeh; Ghislaine Dehaene-Lambertz; Fabrice Wallois
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.